{"id":5543,"date":"2017-06-30T13:55:00","date_gmt":"2017-06-30T13:55:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5543"},"modified":"2021-07-12T08:00:01","modified_gmt":"2021-07-12T08:00:01","slug":"therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/","title":{"rendered":"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics."},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kanekura+T&amp;cauthor_id=28771892\">Takuro Kanekura<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Seishima+M&amp;cauthor_id=28771892\">Mariko Seishima<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Honma+M&amp;cauthor_id=28771892\">Masaru Honma<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Etou+T&amp;cauthor_id=28771892\">Takafumi Etou<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-4\">4<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Eto+H&amp;cauthor_id=28771892\">Hikaru Eto<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-5\">5<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Okuma+K&amp;cauthor_id=28771892\">Keiko Okuma<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-6\">6<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Okubo+Y&amp;cauthor_id=28771892\">Yukari Okubo<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-7\">7<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yamaguchi+Y&amp;cauthor_id=28771892\">Yukie Yamaguchi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-8\">8<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kambara+T&amp;cauthor_id=28771892\">Takeshi Kambara<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-9\">9<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mabuchi+T&amp;cauthor_id=28771892\">Tomotaka Mabuchi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-10\">10<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Suga+Y&amp;cauthor_id=28771892\">Yasushi Suga<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-11\">11<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Morita+A&amp;cauthor_id=28771892\">Akimichi Morita<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-12\">12<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yamanishi+K&amp;cauthor_id=28771892\">Kiyofumi Yamanishi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-13\">13<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tsuruta+D&amp;cauthor_id=28771892\">Daisuke Tsuruta<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-14\">14<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Itoh+K&amp;cauthor_id=28771892\">Kei Itoh<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-15\">15<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yamaji+K&amp;cauthor_id=28771892\">Ken Yamaji<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-16\">16<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ikeda+S&amp;cauthor_id=28771892\">Shigaku Ikeda<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/#affiliation-6\">6<\/a><\/sup> , J Dermatol. 2017 Dec;44(12):1353-1359.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>This study demonstrates that GMA with the Adacolumn was effective with good safety profile in patients with PsA refractory to pharmacologicals. The results indicate a major role for myeloid leukocytes in the immunopathogenesis of PsA. A large controlled study is warranted to fully evaluate the efficacy of Adacolumn GMA in patients with PsA.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28771892\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Takuro Kanekura&nbsp;1,&nbsp;Mariko Seishima&nbsp;2,&nbsp;Masaru Honma&nbsp;3,&nbsp;Takafumi Etou&nbsp;4,&nbsp;Hikaru Eto&nbsp;5,&nbsp;Keiko Okuma&nbsp;6,&nbsp;Yukari Okubo&nbsp;7,&nbsp;Yukie Yamaguchi&nbsp;8,&nbsp;Takeshi Kambara&nbsp;9,&nbsp;Tomotaka Mabuchi&nbsp;10,&nbsp;Yasushi Suga&nbsp;11,&nbsp;Akimichi Morita&nbsp;12,&nbsp;Kiyofumi Yamanishi&nbsp;13,&nbsp;Daisuke Tsuruta&nbsp;14,&nbsp;Kei Itoh&nbsp;15,&nbsp;Ken Yamaji&nbsp;16,&nbsp;Shigaku Ikeda&nbsp;6 , J Dermatol. 2017 Dec;44(12):1353-1359. This study demonstrates that GMA with the Adacolumn was effective with good safety profile in patients with PsA refractory to pharmacologicals. The results indicate a major role for myeloid leukocytes in the [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[147,307],"class_list":["post-5543","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-dermatology"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Takuro Kanekura&nbsp;1,&nbsp;Mariko Seishima&nbsp;2,&nbsp;Masaru Honma&nbsp;3,&nbsp;Takafumi Etou&nbsp;4,&nbsp;Hikaru Eto&nbsp;5,&nbsp;Keiko Okuma&nbsp;6,&nbsp;Yukari Okubo&nbsp;7,&nbsp;Yukie Yamaguchi&nbsp;8,&nbsp;Takeshi Kambara&nbsp;9,&nbsp;Tomotaka Mabuchi&nbsp;10,&nbsp;Yasushi Suga&nbsp;11,&nbsp;Akimichi Morita&nbsp;12,&nbsp;Kiyofumi Yamanishi&nbsp;13,&nbsp;Daisuke Tsuruta&nbsp;14,&nbsp;Kei Itoh&nbsp;15,&nbsp;Ken Yamaji&nbsp;16,&nbsp;Shigaku Ikeda&nbsp;6 , J Dermatol. 2017 Dec;44(12):1353-1359. This study demonstrates that GMA with the Adacolumn was effective with good safety profile in patients with PsA refractory to pharmacologicals. The results indicate a major role for myeloid leukocytes in the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T08:00:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/\",\"name\":\"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2017-06-30T13:55:00+00:00\",\"dateModified\":\"2021-07-12T08:00:01+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/","og_locale":"fr_FR","og_type":"article","og_title":"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. - Adacyte","og_description":"Takuro Kanekura&nbsp;1,&nbsp;Mariko Seishima&nbsp;2,&nbsp;Masaru Honma&nbsp;3,&nbsp;Takafumi Etou&nbsp;4,&nbsp;Hikaru Eto&nbsp;5,&nbsp;Keiko Okuma&nbsp;6,&nbsp;Yukari Okubo&nbsp;7,&nbsp;Yukie Yamaguchi&nbsp;8,&nbsp;Takeshi Kambara&nbsp;9,&nbsp;Tomotaka Mabuchi&nbsp;10,&nbsp;Yasushi Suga&nbsp;11,&nbsp;Akimichi Morita&nbsp;12,&nbsp;Kiyofumi Yamanishi&nbsp;13,&nbsp;Daisuke Tsuruta&nbsp;14,&nbsp;Kei Itoh&nbsp;15,&nbsp;Ken Yamaji&nbsp;16,&nbsp;Shigaku Ikeda&nbsp;6 , J Dermatol. 2017 Dec;44(12):1353-1359. This study demonstrates that GMA with the Adacolumn was effective with good safety profile in patients with PsA refractory to pharmacologicals. The results indicate a major role for myeloid leukocytes in the [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T08:00:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/","name":"Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2017-06-30T13:55:00+00:00","dateModified":"2021-07-12T08:00:01+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/therapeutic-depletion-of-myeloid-lineage-leukocytes-by-adsorptive-apheresis-for-psoriatic-arthritis-efficacy-of-a-non-drug-intervention-for-patients-refractory-to-pharmacologics\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5543"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}